# Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast
Canonical URL: https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-second-quarter-conference-call-and-webcast
Ticker: AZTA
Company: Azenta Life Sciences
Source: Azenta Life Sciences
Published: 2026-04-29 20:06 EST
Original Source URL: https://investors.azenta.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-08 12:00 EST — [Azenta Completes Sale of B Medical Systems](https://biopharmsignal.com/news/AZTA/azenta-completes-sale-of-b-medical-systems-869ef834) — Source: Azenta Life Sciences
- 2026-05-21 20:05 EST — [Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report](https://biopharmsignal.com/news/AZTA/azenta-publishes-2025-environmental-social-and-governance-esg-report) — Source: Azenta Life Sciences
- 2026-05-05 20:30 EST — [Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029](https://biopharmsignal.com/news/AZTA/azenta-reports-second-quarter-results-for-fiscal-2026-ended-march-31-2026-updates-full-year-fiscal-2026-guidance-and-extends-long-range-plan-to-2029) — Source: Azenta Life Sciences
- 2026-04-29 20:06 EST — [Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-second-quarter-conference-call-and-webcast) — Source: Azenta Life Sciences
- 2026-04-07 12:15 EST — [Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution](https://biopharmsignal.com/news/AZTA/azenta-life-sciences-announces-leadership-transition-to-accelerate-gene-synthesis-strategy-and-multiomics-execution) — Source: Azenta Life Sciences
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)